Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1003381 | 0.96 | TSHR (0.31) | ALDH1A1TSHRTDP1 | |
| SCHEMBL107947 | 0.96 | ALDH1A1 (0.36) | ALDH1A1TSHRTDP1 | |
| SCHEMBL9293251 | 0.93 | — | — | |
| SCHEMBL3889962 | 0.92 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| Water SCHEMBL11536125 | 0.92 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL590 | 0.92 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL3898656 | 0.92 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| Lithium Ion SCHEMBL808460 | 0.88 | TSHR (0.31) | ALDH1A1TSHRTDP1 | |
| SCHEMBL3898653 | 0.88 | TSHR (0.31) | ALDH1A1TSHRTDP1 | |
| Potassium Ion SCHEMBL3889958 | 0.88 | TSHR (0.31) | ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113968892-B | Reducing composition and preparation method and application of brassinolide homolog intermediate | 湖南科瑞生物制药股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| EP-2865666-B1 | HEXAHYDROPENTALENO DERIVATIVES, PREPARATION METHOD AND USE IN MEDICINE THEREOF | SUNSHINE LAKE PHARMA CO LTD (CN) | 2017-05-31 | — | — | EP | claimed |
| US-20150299118-A1 | HEXAHYDROPENTALENO DERIVATIVES, PREPARATION METHOD AND USE IN MEDICINE THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2015-10-22 | — | — | US | claimed |
| EP-2865666-A1 | HEXAHYDROPENTALENO DERIVATIVES, PREPARATION METHOD AND USE IN MEDICINE THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2015-04-29 | — | — | EP | claimed |
| US-6852350-B2 | Flavor precursors | FITZ WOLFGANG (NL) | 2005-02-08 | — | — | US | claimed |
| US-6713642-B2 | Method for producing alkali metal monohydridoborates and monohydridoaluminates | CHEMETALL GMBH (DE) | 2004-03-30 | — | — | US | claimed |
| EP-1272496-B1 | METHOD FOR PRODUCING ALKALI METAL MONOHYDRIDOBORATES AND MONOHYDRIDOALUMINATES | CHEMETALL GMBH (DE) | 2004-01-28 | — | — | EP | claimed |
| US-20030166956-A1 | Method for producing alkali metal monohydridoborates and monohydridoaluminates | CHEMETALL GMBH (DE) | 2003-09-04 | — | — | US | claimed |
| US-20020037349-A1 | Flavour precursors | FITZ WOLFGANG (NL) | 2002-03-28 | — | — | US | claimed |
| US-4908439-A | Synthesis of intermediate useful in the preparation of nojirimycin and related compounds | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-03-13 | — | — | US | claimed |
| US-4868298-A | Continuous process for the production of blocked isocyanate containing polyisocyanurates | CARGILL, INCORPORATED (US) | 1989-09-19 | — | — | US | claimed |
| US-4423209-A | REACTING TO CONVERT 5-METHOXY GROUP TO HYDROXY | MERCK & CO., INC. (US) | 1983-12-27 | — | — | US | claimed |
| CN-118344420-A | Preparation method of deoxycholic acid | 北京诺博特生物科技有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-3645548-B1 | METHODS FOR PREPARING BILE ACIDS | MEDYTOX INC (KR) | 2023-11-29 | — | — | EP | disclosed |
| CN-111328332-B | Process for the preparation of bile acids | 玫帝托克斯股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-113968892-B | Reducing composition and preparation method and application of brassinolide homolog intermediate | 湖南科瑞生物制药股份有限公司 | 2022-12-23 | — | — | CN | disclosed |
| US-3931284-A | 11β-PGE2 compounds | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931283-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931289-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931279-A | 5-Oxa prostaglandin F2.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166956-A1 | Method for producing alkali metal monohydridoborates and monohydridoaluminates | ME1, CA7, ME3 | ALDH1A1 679/4885TSHR 3324/4885TDP1 4754/4885 |
| US-20150299118-A1 | HEXAHYDROPENTALENO DERIVATIVES, PREPARATION METHOD AND USE IN MEDICINE THEREOF | DPP4, DPP7, DPP3 | ALDH1A1 188/4885TSHR 2088/4885TDP1 2808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.